Form 4: Elicio Therapeutics Executive Receives Stock Grant
Insider Transaction (Form 4)
Preetam Shah, See Remarks of Elicio Therapeutics, Inc., received 60,833 shares of common stock on July 16, 2026.
Summary
- Grant/award: acquired 60,833 Stock Option (Right to Buy) on July 16, 2026; holds 60,833 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Preetam Shah — Officer (See Remarks)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-16 | Grant/award | Stock Option (Right to Buy) | 60,833 | — | — | 60,833 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-16 | Grant/award (60,833 shares) |
Keywords
insider transaction, Form 4, ELTX, Elicio Therapeutics, Inc., neutral, Preetam Shah
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.